785 articles
New research links adult weight gain to 5x higher cancer risk, while post-surgery walking cuts complications and readmission rates significantly.
A phase IIIb trial finds adding tirzepatide to standard psoriasis treatment nearly triples complete skin clearance and drives meaningful weight loss.
New research links serotonin to tinnitus worsening, with major implications for the millions taking SSRIs for depression or anxiety.
A new MIT-led therapy uses mRNA nanoparticles to rewire immune cells from within, achieving complete tumor regression in most treated mice.
Diranersen reduced tau biomarkers and slowed cognitive decline in early Alzheimer's patients, marking a milestone for tau-directed therapy.
A Phase 1b trial drug may prevent post-surgical liver failure by accelerating liver regeneration, expanding options for cancer patients.
NeuroVision acquires Durin Life Sciences to combine blood biomarkers and retinal imaging for earlier Alzheimer's and Parkinson's detection.
RTX001, a regenerative macrophage cell therapy, reduced liver inflammation and fibrosis in mouse models ahead of Phase I/II trial results.
RZ-001 earns rare RMAT designation for hepatocellular carcinoma, signaling RNA editing's rise as a precise, programmable cancer treatment.
AlzeCure's ACD137 shows pain relief and joint protection in preclinical models, offering a safer alternative to opioids for 600M sufferers.
As DEXA body composition testing booms in longevity circles, a new quality standard aims to separate trustworthy data from cheap, unreliable scans.
Buck Institute finds APOE2 boosts DNA repair and blocks cellular senescence in neurons, reframing Alzheimer's protection.
